...
首页> 外文期刊>Allergy & Rhinology >A rare and emerging entity: Sinonasal IgG4‐related sclerosing disease
【24h】

A rare and emerging entity: Sinonasal IgG4‐related sclerosing disease

机译:罕见的新兴实体:鼻鼻IgG4相关性硬化病

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background: Immunoglobulin G4 (IgG4) related sclerosing disease (rSD) is a new disease entity, first described in 2001, that involves autoimmune pancreatitis. Considered a systemic disease with lesions described in multiple organ systems, IgG4-rSD that affects the sinonasal region is rare. Our goal was to highlight the sinonasal presentation of this unique disease and to review previously reported adult cases from 2003 to 2014. Methods: Case report (a 72-year-old man who presented with left exophthalmos, periorbital pain, and epiphora) and review of the literature. Results: Radiographic workup with computed tomography and magnetic resonance imaging demonstrated a left sinonasal mass that involved the left maxillary and ethmoid sinuses, with surrounding bony destruction and orbital invasion. Nasal endoscopy demonstrated a fibrous lesion emanating in the middle meatus, with surrounding mucosal inflammation. The patient underwent an endoscopic biopsy, medial maxillectomy, and ethmoidectomy with tumor debulking. Pathology demonstrated inflamed respiratory mucosa with dense lymphoplasmacytic infiltrate and fibrosis; flow cytometry demonstrated no malignant cell populations; immunophenotyping demonstrated multiple foci of IgG4 cells. Plasma IgG4 was elevated in the setting of normal total IgG. The patient was treated with postoperative systemic and topical corticosteroids. Surveillance imaging studies and nasal endoscopy demonstrated disease resolution without recurrence. Conclusions: Sinonasal IgG4-rSD is a rare disease that can present with bony and soft-tissue invasion. This was an exceptional case, with osseous involvement and orbital invasion. Immunohistologic workup is essential for diagnosis. It is important to differentiate this disease from sinonasal tumors. Treatment includes corticosteroids and surgical debulking. Sinonasal IgG4-rSD represents an emerging disease that may present challenges for future rhinologists.
机译:背景:免疫球蛋白G4(IgG4)相关性硬化性疾病(rSD)是一种新的疾病实体,于2001年首次描述,涉及自身免疫性胰腺炎。被认为是具有在多个器官系统中描述的病变的全身性疾病,影响鼻窦区域的IgG4-rSD很少见。我们的目标是突出显示这种独特疾病的鼻窦表现,并回顾先前报告的2003年至2014年成年病例。方法:病例报告(72岁的男性患者,患有左眼球突出症,眼眶周围疼痛和泪溢)并进行回顾文学。结果:X线计算机断层扫描和磁共振成像检查显示左鼻窦肿块累及左上颌窦和筛窦,周围骨质破坏和眼眶侵犯。鼻内窥镜检查显示在中耳道有纤维性病变,周围有粘膜炎症。该患者接受了内镜下活检,上颌内侧切除术和筛窦切除术并伴有肿瘤。病理显示呼吸道黏膜发炎,并有密集的淋巴浆细胞浸润和纤维化。流式细胞术未见恶性细胞群。免疫表型证实了IgG4细胞的多个病灶。在正常总IgG水平下血浆IgG4升高。术后接受全身和局部皮质类固醇激素治疗。监视影像学研究和鼻内窥镜检查证明疾病可以消退而不会复发。结论:鼻鼻IgG4-rSD是一种罕见的疾病,可出现骨性和软组织侵袭。这是一个例外情况,有骨性累及和眶侵犯。免疫组织学检查对诊断至关重要。区分这种疾病和鼻窦肿瘤很重要。治疗包括皮质类固醇激素和外科手术治疗。鼻鼻IgG4-rSD代表一种正在出现的疾病,可能对未来的鼻科医师提出挑战。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号